×

Subscribe Today

Get our free articles delivered directly to your email!

Continue reading

Aura Biosciences Inc. (AURA) NASDAQ

$7.85 0.15 (1.95%)

Market Cap: $388.61M

As of 03/28/24 04:00 PM EDT. Market closed.

(AURA)

Aura Biosciences Inc. (AURA)
NASDAQ

$7.85
0.15 (1.95%)

Market Cap: $388.61M

As of 03/28/24 04:00 PM EDT. Market closed.

Add to Portfolio

at aura biosciences, we are developing a new class of therapies to target and destroy cancer cells selectively, while leaving surrounding tissue unharmed – an approach we call molecular surgery. by safely eliminating cancer locally, we can treat early and transform the lives of people with a wide range of cancers that are poorly managed today. our lead program in ocular melanoma (om), also ... read more

at aura biosciences, we are developing a new class of therapies to target and destroy cancer cells selectively, while leaving surrounding tissue unharmed – an approach we call molecular surgery. by safely eliminating cancer locally, we can treat early and transform the lives of people with a wide range of cancers that are poorly managed today. our lead program in ocular melanoma (om), also known as choroidal or uveal melanoma, is designed to remove cancer cells in the back of the eye as a first-line therapy, while allowing for the potential of preserving patients’ vision. the goal is to treat small ocular melanomas potentially long before the disease progresses and metastasizes to the liver, where it almost always is fatal. development of a first-in-class, non-radioactive treatment option to selectively destroy cancer cells would create the possibility to transform the treatment of this and other cancers where the disease can be detected early. by enabling physicians to treat cancer mo read less

COMPANY PROFILE
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology
URL
Address
.
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology
URL
Address
.
PRICE CHART FOR AURA BIOSCIENCES INC
1w
1m
3m
6m
YTD
1y
5y
MAX
From: To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$7.66
Previous Close
$7.70
Days Range
$7.29 - $7.93
52 week range
$5.99 - $13.50
Volume
323,835
Avg. Volume (30 days)
314,982
Market Cap
$388.61M
Dividend Yield
-
P/E
-
Shares Outstanding
49,504,405
Open
$7.66
Previous Close
$7.70
Days Range
$7.29 - $7.93
52 week range
$5.99 - $13.50
Volume
323,835
Avg. Volume (30 days)
314,982
Market Cap
$388.61M
Dividend Yield
-
P/E
-
Shares Outstanding
49,504,405
FINANCIAL STATEMENTS FOR AURA BIOSCIENCES INC
LOADING...

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR AURA BIOSCIENCES INC
OwnerRelationshipDateTransactionCost# SharesValue($)Total SharesForm 4
de los Pinos ElisabetSee RemarksJan 23, 2024 Sale$7.6415,853121,141161,438Jan 24, 2024, 04:20 PM
Feder Julie BChief Financial OfficerJan 23, 2024 Sale$7.646,60950,52162,991Jan 24, 2024, 04:18 PM
Johnson David MichaelDirectorNov 07, 2023 Buy$7.1794,000673,98065,000Nov 09, 2023, 05:02 PM
Johnson David MichaelDirectorNov 07, 2023 Buy$7.1776,000544,920126,066Nov 09, 2023, 05:02 PM
Johnson David MichaelDirectorNov 08, 2023 Buy$7.3010,00073,00075,000Nov 09, 2023, 05:02 PM
Johnson David MichaelDirectorNov 08, 2023 Buy$7.3010,00073,00075,000Nov 09, 2023, 05:02 PM
Johnson David MichaelDirectorNov 08, 2023 Buy$7.309,60170,087135,667Nov 09, 2023, 05:02 PM
Matrix Capital Management Company, LP10% OwnerNov 09, 2023 Buy$9.001,560,00014,040,0006,922,870Nov 09, 2023, 04:35 PM
de los Pinos ElisabetSee RemarksNov 06, 2023 Option Exercise$2.743,80010,412184,740Nov 07, 2023, 06:19 PM
de los Pinos ElisabetSee RemarksNov 06, 2023 Sale$12.037,44989,611177,291Nov 07, 2023, 06:19 PM
Feder Julie BChief Financial OfficerNov 06, 2023 Option Exercise$2.743,90010,68673,500Nov 07, 2023, 06:09 PM
Feder Julie BChief Financial OfficerNov 06, 2023 Sale$12.073,90047,05469,600Nov 07, 2023, 06:09 PM
Feder Julie BChief Financial OfficerOct 30, 2023 Sale$6.823,38523,09169,600Nov 01, 2023, 06:24 PM
de los Pinos ElisabetSee RemarksOct 30, 2023 Sale$6.839,58665,478180,940Nov 01, 2023, 06:21 PM
Johnson David MichaelDirectorOct 04, 2023 Buy$8.616,56656,51250,066Oct 05, 2023, 07:56 PM
Johnson David MichaelDirectorOct 03, 2023 Buy$8.2713,500111,66343,500Oct 05, 2023, 07:56 PM
Johnson David MichaelDirectorJan 06, 2023 Buy$10.507007,35018,000Jan 09, 2023, 05:55 PM
Johnson David MichaelDirectorJan 05, 2023 Buy$10.009696017,096Jan 09, 2023, 05:55 PM
Johnson David MichaelDirectorJan 05, 2023 Buy$10.003003,00017,300Jan 09, 2023, 05:55 PM
Johnson David MichaelDirectorJan 06, 2023 Buy$10.519049,50118,000Jan 09, 2023, 05:55 PM
Johnson David MichaelDirectorDec 28, 2022 Buy$9.752,00019,50017,000Dec 30, 2022, 07:01 PM
Johnson David MichaelDirectorDec 28, 2022 Buy$9.752,00019,50017,000Dec 30, 2022, 07:01 PM
Johnson David MichaelDirectorDec 01, 2022 Buy$12.375,00061,85015,000Dec 15, 2022, 06:15 PM
Johnson David MichaelDirectorDec 01, 2022 Buy$12.375,00061,85015,000Dec 15, 2022, 06:15 PM
Matrix Capital Management Company, LP10% OwnerDec 05, 2022 Buy$12.001,250,00015,000,0005,362,870Dec 07, 2022, 04:30 PM
Feder Julie BChief Financial OfficerOct 31, 2022 Sale$12.452,01525,09024,235Nov 02, 2022, 08:39 PM
Rich CadmusSee RemarksOct 31, 2022 Sale$12.451,67220,81324,578Nov 02, 2022, 08:38 PM
de los Pinos ElisabetSee RemarksOct 31, 2022 Sale$12.465,70671,08268,651Nov 02, 2022, 08:37 PM
De Rosch MarkChief Operating OfficerOct 31, 2022 Sale$12.461,11513,89016,385Nov 02, 2022, 08:36 PM
Johnson David MichaelDirectorJun 13, 2022 Buy$13.997,00097,93010,000Jun 14, 2022, 09:29 PM
Johnson David MichaelDirectorJun 13, 2022 Buy$13.997,00097,93010,000Jun 14, 2022, 09:29 PM
Johnson David MichaelDirectorJun 10, 2022 Buy$15.0410,000150,40010,000Jun 14, 2022, 09:29 PM
Johnson David MichaelDirectorJun 10, 2022 Buy$15.043,00045,1203,000Jun 14, 2022, 09:29 PM
Johnson David MichaelDirectorJun 10, 2022 Buy$15.043,00045,1203,000Jun 14, 2022, 09:29 PM
Johnson David MichaelDirectorJun 13, 2022 Buy$13.9920,000279,80030,000Jun 14, 2022, 09:29 PM
Medicxi Ventures Management (Jersey) Ltd10% OwnerNov 02, 2021 Buy$14.00710,0009,940,0002,969,352Nov 04, 2021, 05:00 PM
Matrix Capital Management Company, LP10% OwnerNov 02, 2021 Buy$14.001,785,00024,990,0004,112,870Nov 04, 2021, 04:44 PM
Load More Insider Transactions
Buy Sale Option Exercise
OwnerRelationshipDateValue($)
de los Pinos ElisabetSee Remarks01/23/2024121,141
Feder Julie BChief Financial Officer01/23/202450,521
Johnson David MichaelDirector11/07/2023673,980
Johnson David MichaelDirector11/07/2023544,920
Johnson David MichaelDirector11/08/202373,000
Johnson David MichaelDirector11/08/202373,000
Johnson David MichaelDirector11/08/202370,087
Matrix Capital Management Company, LP10% Owner11/09/202314,040,000
de los Pinos ElisabetSee Remarks11/06/202310,412
de los Pinos ElisabetSee Remarks11/06/202389,611
Feder Julie BChief Financial Officer11/06/202310,686
Feder Julie BChief Financial Officer11/06/202347,054
Feder Julie BChief Financial Officer10/30/202323,091
de los Pinos ElisabetSee Remarks10/30/202365,478
Johnson David MichaelDirector10/04/202356,512
Johnson David MichaelDirector10/03/2023111,663
Johnson David MichaelDirector01/06/20237,350
Johnson David MichaelDirector01/05/2023960
Johnson David MichaelDirector01/05/20233,000
Johnson David MichaelDirector01/06/20239,501
Johnson David MichaelDirector12/28/202219,500
Johnson David MichaelDirector12/28/202219,500
Johnson David MichaelDirector12/01/202261,850
Johnson David MichaelDirector12/01/202261,850
Matrix Capital Management Company, LP10% Owner12/05/202215,000,000
Feder Julie BChief Financial Officer10/31/202225,090
Rich CadmusSee Remarks10/31/202220,813
de los Pinos ElisabetSee Remarks10/31/202271,082
De Rosch MarkChief Operating Officer10/31/202213,890
Johnson David MichaelDirector06/13/202297,930
Johnson David MichaelDirector06/13/202297,930
Johnson David MichaelDirector06/10/2022150,400
Johnson David MichaelDirector06/10/202245,120
Johnson David MichaelDirector06/10/202245,120
Johnson David MichaelDirector06/13/2022279,800
Medicxi Ventures Management (Jersey) Ltd10% Owner11/02/20219,940,000
Matrix Capital Management Company, LP10% Owner11/02/202124,990,000
Load More Insider Transactions
FUNDS WITH A POSITION IN AURA BIOSCIENCES INC
Fund# Shares Owned% of Portfolio% ChangeInvesting Style
MATRIX CAPITAL MANAGEMENT COMPANY, LP6,922,8700.63%29.09%Growth
ADAGE CAPITAL PARTNERS GP, L.L.C.4,225,0000.08%46.96%Other
BLACKROCK INC.2,098,7450.00047%12.59%Other
GEODE CAPITAL MANAGEMENT, LLC676,1280.00063%28.43%Other
PLATINUM INVESTMENT MANAGEMENT LTD180,1450.06%NewGrowth At A Reasonable Price, Value
UBS OCONNOR LLC90,0000.06%104.55%Value
D. E. SHAW & CO., INC.60,0640.00047%NewOther
ALPS ADVISORS INC33,6600.00234%19.54%Other
RENAISSANCE TECHNOLOGIES LLC28,5000.00039%111.11%Other
WATER ISLAND CAPITAL LLC22,6500.02%ExitedEvent Driven
CHANGE IN SHARES OUTSTANDING FOR AURA BIOSCIENCES INC
STOCK BUYBACKS FOR AURA BIOSCIENCES INC
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
12/31/2023
09/30/2023
16.93%
1Q
12/31/2023
06/30/2023
17.95%
2Q
12/31/2023
03/31/2023
18.17%
3Q
12/31/2023
12/31/2022
39.49%
4Q
12/31/2023
09/30/2022
52.53%
5Q
12/31/2023
06/30/2022
52.64%
6Q
12/31/2023
03/31/2022
52.84%
7Q
Load More

Period of Report: 12/31/2023

10-K/10-Q Filings: View

Previous Period
% Change in Shares
Quarter
09/30/2023
16.93%
1Q
06/30/2023
17.95%
2Q
03/31/2023
18.17%
3Q
12/31/2022
39.49%
4Q
09/30/2022
52.53%
5Q
06/30/2022
52.64%
6Q
03/31/2022
52.84%
7Q
Load More
BUYBACK ANNOUNCEMENT(S) FOR AURA BIOSCIENCES INC
LOADING...